Startup valuation and pre-diligence checks — vc-scan
The Podium
which idea more than one company is chasing16 Aug – 13 Nov
Defence & national security
UFORCE, Onodrim Industries, Warhound, Hypersonica, Beyond Vision, SE3, HEO, INLEAP Photonics, Buntar Aerospace, Gallium Defense, DOD Solution, Arke Telekom, Freya Industries, SpaceAM
$1.5bn reported
AI agents doing the work
Butterfly Effect, Future Secure AI, Ema, Vesta, Zeliq, Primo, Opply, 50skills, Mondrio, Itoflow
$722.7m reported
Chips built for AI
Tenstorrent, Fractile, FuriosaAI, EUCLYD, Nano-core Chip, Moffett AI, Ubitium, Groq, SUNMMIO
$3.4bn reported
The Intake
who raised · what they're building- Other B2B Software3620%$1.1bn
- Robotics169%$1.2bn
- Semiconductors137%$3.4bn
- AI137%$1.7bn
- Defence106%$1.4bn
- 13 NovIncision€4m(reported)
Software that walks operating-theatre and sterilisation staff through the preparation each surgical procedure needs.
- 13 NovRefilledAUD 5.6m(reported)
Plumbed-in drinks taps for offices, sold as a way to stop buying bottled drinks.
- 13 NovVectorY Therapeutics€74.5m(reported)
Develops antibody treatments delivered into the body by a virus carrier, aimed at ALS and other nerve-wasting diseases.
Dry Powder
who's writing cheques583 firms backed a startup in the last 90 days. 9 in 10 did it once.
firms named in the rounds we collected · 60% of rounds name an investor
- 6 companiesSeedcamp
- 5 companiesHTGF·Nvidia·Y Combinator
- 1 company506
- 2 companies59
- 3 companies10
- 4+ companies8
The Diligence Desk
Who's writing cheques: the firms backing the most startups, to 13 Nov
Which investors are actually backing startups right now, what they back, and who just started.
read it→We read every company behind our own ranking of crowded startup ideas. Fixing it showed three things worth knowing.
Which investors are actually backing startups right now, what they back, and who just started.
Which investors are actually backing startups right now, what they back, and who just started.
We ran one real company through every check we have. Here is what the public record shows, and what we would ask.
Drug start-ups are valued on the odds their medicine survives its trials, not on revenue. Here's how that works.
Everything above came out of a free public record.
The same check runs on your company in about a minute — overdue filings, charges still on the register, an ownership record that doesn't match your deck. Better you see it first.
run it on your own company→